Search results for: Value-Based Pricing
Filter search results
Early Diagnosis of Visual Defects
1 July 1967
…based entirely on the reduction of intra-ocular pressure. Detection of the disease is frequently by measurement of this pressure by tonometry, but this presents problems in that it is not…
Is There a Productivity Crisis in Pharmaceutical R&D?
6 January 2012
…changes in both the regulatory and marketing climates. In addition to describing overall trends, Prof Riccaboni also compares the R&D performance of companies based in the US and Europe, and…
Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective
1 August 2008
…the circumstances in which each could be used. Although such methods can help inform and improve regulatory decision making, these difficult decisions will always require judgments based on multiple considerations….
No cure, no fee?
25 September 2023
Discover key takeaways from @ProgressEduTrust’s article by @nadine_h22 & @Amanda_M_Cole about outcome-based agreements for gene therapies. Read more on X….
Medicines, Health and the Poor World
1 April 1982
…allocation in most developing countries was too heavily biased towards urban, hospital based, curative medicine, OHE noted that in many poor countries two thirds to three quarters of public health…
Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry
3 January 1982
…The first concerned prices; this second paper is concerned, by contrast, with the costs of pharmaceutical innovation. This study by Keith Hartley and Alan Maynard is based on a survey…
Needs of the Pharmaceutical Manufacturers from Their Medical Departments in the 1980s
1 February 1983
…the Directors of several individual Medical Departments in Britain, on whose expertise the study is based. The conclusions and predictions are, however, my own responsibility. I trust they may be…
Issues in Development: a Guide
5 January 1983
…them. Dr Leisinger stresses the need to utilise technologically based contributions to development prudently; that is in a manner compatible with the social and cultural conditions prevailing in each less…
Consumer Movement, Health, and the Pharmaceutical Industry
1 January 1983
…deny the value of extensive legal and financial interventions designed to protect those in need of care and support from the hazards of an untrammelled market. Yet at the same…